Summary of the values of passive force, maximal active force, pCa50, and nH in PLV with and without pimobendan
| SL | Passive force | Maximal force | pCa50 | ΔpCa50 | nH | |
| μm | mN/mm2 | mN/mm2 | ||||
| Without sTn reconstitution | ||||||
| Vehicle | 1.9 | ∼0 | 55.58 ± 3.97 | 5.55 ± 0.01 | 3.72 ± 0.14 | |
| 2.3 | 8.90 ± 0.52 | 76.68 ± 2.94 | 5.77 ± 0.01 | 0.22 ± 0.01 | 3.21 ± 0.04 | |
| +Pimobendan | 1.9 | ∼0 | 44.98 ± 3.76 | 5.77 ± 0.03a | 2.87 ± 0.13a | |
| 2.3 | 8.74 ± 1.04 | 61.81 ± 5.92 | 5.97 ± 0.02a | 0.20 ± 0.02 | 2.53 ± 0.25a | |
| With sTn reconstitution | ||||||
| Vehicle | 1.9 | ∼0 | 53.68 ± 3.47 | 5.80 ± 0.01a | 3.29 ± 0.07a | |
| 2.3 | 8.88 ± 0.36 | 59.96 ± 3.15a | 5.93 ± 0.01a | 0.14 ± 0.01a | 3.45 ± 0.11 | |
| +Pimobendan | 1.9 | ∼0 | 51.52 ± 2.14 | 5.82 ± 0.01a | 3.68 ± 0.13 | |
| 2.3 | 9.37 ± 1.03 | 60.15 ± 3.55a | 5.96 ± 0.01a | 0.14 ± 0.01a | 3.82 ± 0.19a | |
| SL | Passive force | Maximal force | pCa50 | ΔpCa50 | nH | |
| μm | mN/mm2 | mN/mm2 | ||||
| Without sTn reconstitution | ||||||
| Vehicle | 1.9 | ∼0 | 55.58 ± 3.97 | 5.55 ± 0.01 | 3.72 ± 0.14 | |
| 2.3 | 8.90 ± 0.52 | 76.68 ± 2.94 | 5.77 ± 0.01 | 0.22 ± 0.01 | 3.21 ± 0.04 | |
| +Pimobendan | 1.9 | ∼0 | 44.98 ± 3.76 | 5.77 ± 0.03a | 2.87 ± 0.13a | |
| 2.3 | 8.74 ± 1.04 | 61.81 ± 5.92 | 5.97 ± 0.02a | 0.20 ± 0.02 | 2.53 ± 0.25a | |
| With sTn reconstitution | ||||||
| Vehicle | 1.9 | ∼0 | 53.68 ± 3.47 | 5.80 ± 0.01a | 3.29 ± 0.07a | |
| 2.3 | 8.88 ± 0.36 | 59.96 ± 3.15a | 5.93 ± 0.01a | 0.14 ± 0.01a | 3.45 ± 0.11 | |
| +Pimobendan | 1.9 | ∼0 | 51.52 ± 2.14 | 5.82 ± 0.01a | 3.68 ± 0.13 | |
| 2.3 | 9.37 ± 1.03 | 60.15 ± 3.55a | 5.96 ± 0.01a | 0.14 ± 0.01a | 3.82 ± 0.19a | |
Data are for Fig. 6. Maximal force was obtained by activating muscle at pCa 4.5 before construction of the force–pCa curve at each SL (passive force was measured just before activation at pCa 4.5). Maximal force obtained before sTn reconstitution: 56.06 ± 3.42 and 54.25 ± 2.20 mN/mm2 for vehicle and pimobendan-treated group, respectively (P > 0.05 compared with the value obtained after sTn reconstitution). Pimobendan did not significantly change maximal force (see Fukuda et al., 2000) with and without sTn reconstitution, and it did not change any parameter in sTn-reconstituted muscles.
P < 0.05 compared with the corresponding values in the vehicle-treated group without sTn reconstitution.